Role of RAS mutation status as a prognostic factor for patients with advanced colorectal cancer treated with first-line chemotherapy based on fluoropyrimidines and oxaliplatin, with or without bevavizumab: A retrospective analysis

The role of Kirsten rat sarcoma viral oncogene homolog (KRAS) and neuroblastoma RAS viral oncogene homolog (NRAS) mutations as negative predictors for anti-epidermal growth factor receptor (EGFR) therapies in metastatic colorectal cancer (CRC) has been firmly established. However, whether the RAS mu...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Mol Clin Oncol
Hlavní autoři: Garde Noguera, Javier, Jantus-Lewintre, Eloisa, Gil-Raga, Mireia, Evgenyeva, Elena, Maciá Escalante, Sonia, Llombart-Cussac, Antonio, Camps Herrero, Carlos
Médium: Artigo
Jazyk:Inglês
Vydáno: D.A. Spandidos 2017
Témata:
Articles
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5403557/
https://ncbi.nlm.nih.gov/pubmed/28451421
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mco.2017.1149
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky